Home / Newsroom
Keep up to date with the latest developments at CDISC and follow our news feeds!
15 Aug 2017

Austin, TX – 15 AUG 2017 – According to the World Health Organization, prostate cancer is one of the five most common types of cancer to affect men globally. In an effort to improve research for prostate cancer, the Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the release of a new Therapeutic Area (TA) Standard for Prostate Cancer in the form of a User Guide for data managers, statisticians, programmers and study managers. In announcing the new CDISC Therapeutic Area User Guide, freely available on the CDISC website, President and CEO David R. Bobbitt stated, “CDISC’s community has built this Therapeutic Area Standard to provide research professionals with guidance on how to represent patient data in clinical research to improve quality, efficiency and cost effectiveness, fostering smarter research to discover new treatments. By building data standards for researchers, we give them a more rapid start up and the capacity to share data with collaborators with less effort.”

26 Jul 2017

Austin, TX – 27 July 2017 – The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the availability of a new Therapeutic Area Standard for Diabetic Kidney Disease in the form of a User Guide for data managers, statisticians, programmers and study managers, which is freely available on the CDISC website. Therapeutic Area User Guides provide research professionals with guidance on how to represent patient data in clinical research to improve quality, efficiency and cost effectiveness, enabling smarter research to unlock cures.

15 Jun 2017 | Rob DiCicco, VP, Clinical Innovation and Digital Platforms, GSK | Clinical Leader

14 Jul 2017

This manuscript, published in the International journal of Medical Informatics, describes the development, validation and evaluation of a real-world clinical trial, embedded in primary care Electronic Health Record Systems and using CDISC standards. This real-world trial is a first; only 'proof of principal pilots' have been conducted until now.

22 Jun 2017 | Jason Monteleone, President, Pivotal Financial Consulting, LLC | Clinical Leader

13 Jun 2017

TUCSON, Ariz., and AUSTIN, Texas – June 13, 2017The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the availability of a Duchenne muscular dystrophy therapeutic area user guide (TAUG-DMD v1.0) for public review. The review period for the TAUG-DMD v1.0 began on May 8, 2017, and runs through July 6, 2017. Qualified researchers and clinicians are encouraged to review TAUG-DMD v1.0 and offer feedback.

17 May 2017

CDISC served as a key stakeholder, providing input to the development of Common Protocol Template (CPT). CPT aligns with NIH/FDA-developed Template connecting the parallel universes of clinical care and research as stated by FDA Commissioner during the CDISC/FDA strategy session in August 2016.

9 May 2017 | Various | Alzheimer’s & Dementia: Translational Research & Clinical Interventions

9 May 2017 | Kit Howard, Director, Education, CDISC and Shannon Labout, VP, Education, CDISC | Interchange Poster

18 Apr 2017

Austin, TX – 18 April 2017– The Clinical Data Interchange Standards Consortium (CDISC) today announced the release of Major Depressive Disorder (MDD) Therapeutic Area User Guide v1.0. The MDD standard is freely available on the CDISC website. Therapeutic Area User Guides provide research professionals with guidance on how to represent patient data in clinical research to improve quality, efficiency and cost effectiveness, enabling smarter research to unlock cures.